Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens

• US 5,662,609 A
• Filed: 04/13/1994
• Issued: 09/02/1997
• Est. Priority Date: 02/26/1990
• Status: Expired due to Term

• Current Assignee: Genzyme Corporation (Sanofi )
• Original Assignee: Endoluminal Therapeutics Incorporated
• Inventors: Slepian, Marvin J.
• Primary Examiner(s): Buiz, Michael
• Assistant Examiner(s): LEWIS, WILLIAM W
• Application Number:
  US08/226,945
• Time in Patent Office: 1,238 Days
• Field of Search: 606/191-195, 128/898, 604/95-103
• US Class Current: 604/101.03
• CPC Class Codes: A61L 24/0031 Hydrogels or hydrocolloids
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 2025/1095 with perfusion means for enabling blood circulation while the balloon is in an inflated state or in a deflated state, e.g. permanent by-pass within catheter shaft
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters

Abstract

The present invention provides a technique for treating diseased portions of tissue lumens by the focal introduction of at least one therapeutic agent at the diseased region. A catheter is positioned in a lumen such that first and second expansile members surround the diseased portion of tissue. The expansile members are expanded to occlude the diseased region and a therapeutic agent is introduced to the occluded diseased region via the catheter. The catheter is allowed to remain in place for a therapeutically effective period of time to allow the therapeutic agent to contact the diseased portion for such a period of time. The catheter arrangement also can be used to occlude a diseased region, remove physiological fluid from the occluded region and subsequently to disrupt the diseased region and/or apply the therapeutic agent. The therapeutic agent can be selected to suppress cell proliferation in the diseased region, and the occluded region can be treated with a medicament to promote vessel healing. The occluded region also can be paved with polymeric material. Finally, the expansile members are contracted and the catheter is removed.

Claims

1. A device for providing localized therapy with a therapeutic agent to a diseased region in a tissue lumen, comprising:

an elongate tubular shaft having a distal region adapted for insertion into a patient and a proximal region adapted to remain outside of the patient;

a monomer or prepolymer solution or an at least partially pre-formed polymeric product associated with the device so as to be formable into a layer of polymeric material in intimate and conforming contact with an irregularly contoured tissue surface proximal to the distal region of the shaft; and

a therapeutic agent in fluid communication with the distal region of the shaft selected to influence the behavior of cells, selected from the group consisting of vasodilating agents, calcium channel blocking drugs, anti-proliferative agents, intercalating agents, growth modulating factors, and anti-inflammatory agents.

2. A device as in claim 1, wherein the precursor is a prepolymeric fluid.

3. A device as in claim 2, wherein the prepolymeric fluid contains a therapeutic agent.

4. A device as in claim 3, wherein the precursor is in at least partially polymerized, polymeric article.

5. A method for providing localized therapy to a diseased region in a tissue lumen, comprising:

occluding a diseased region in a tissue lumen;

removing physiological fluid from the tissue lumen at the diseased region; and

subsequently disrupting the diseased region of the tissue lumen to loosen diseased tissue.

6. A method as in claim 5, further comprising contacting the occluded region, for a therapeutically effective period of time, with a therapeutic agent.

7. A method as in claim 6, wherein the therapeutic agent is selected from the group consisting of anti-thrombotic agents, thrombolytic agents, vasodilating agents, calcium channel blocking drugs, anti-proliferative agents, intercalating agents, growth modulating factors, and anti-inflammatory agents.

8. A method as in claim 5, further comprising the step of paving the diseased region of the tissue lumen.

9. A method as in claim 5, the method comprising introducing a device including an elongate tubular shaft into the tissue lumen, the shaft having a distal region adapted for insertion into a patient and a proximal region adapted to remain outside of the patient, an occlusion element at the distal region, and a fluid pathway connecting a reservoir at the proximal region with a port at the distal region.

10. A method as in claim 9, the device comprising a catheter including a flexible elongate tubular shaft and first and second occlusion elements at the distal region of the shaft, the port located between the first and second occlusion elements.

11. A method for providing localized therapy with a therapeutic agent to a diseased region in a tissue lumen, comprising:

occluding the diseased region of the tissue lumen;

contacting the diseased region, for a therapeutically effective period of time, with a therapeutic agent; and

paving the diseased region of the tissue lumen.

12. A method as in claim 11, further comprising, prior to the step of contacting the diseased region of tissue lumen with the therapeutic agent, the step of removing physiological fluid from the tissue lumen at the diseased region.

13. A method as in claim 11, the method comprising introducing a device including an elongate tubular shaft into the tissue lumen, the shaft having a distal region adapted for insertion into a patient and a proximal region adapted to remain outside of the patient, an occlusion element at the distal region, a reservoir of therapeutic agent at the proximal region, and a fluid pathway connecting the reservoir at the proximal region with a port at the distal region.

14. A method as in claim 13, the device comprising a catheter including a flexible elongate tubular shaft and first and second occlusion elements at the distal region of the shaft, the port located between the first and second occlusion elements.

15. A method as in claim 11, further comprising the step of disrupting the diseased region of the tissue lumen.

22. A method as in any of claims 5, 11, or 16, wherein the tissue lumen is the interior of a blood vessel.

16. A method for providing localized therapy to a diseased region in a tissue lumen, comprising:

occluding a diseased region in a tissue lumen;

removing physiological fluid from the tissue lumen at the diseased region; and

subsequently contacting the diseased region, for a therapeutically effective period of time, with a therapeutic agent selected to influence the behavior of cells, selected from the group consisting of vasodilating agents, calcium channel blocking drugs, anti-proliferative agents, intercalating agents, growth modulating factors, and anti-inflammatory agents.

17. A method as in claim 16, the method comprising introducing a device including an elongate tubular shaft into the tissue lumen, the shaft having a distal region adapted for insertion into a patient and a proximal region adapted to remain outside of the patient, an occlusion element at the distal region, a reservoir of therapeutic agent at the proximal region, and a fluid pathway connecting the reservoir at the proximal region with a port at the distal region.

18. A method as in claim 16, further comprising the step of paving the diseased region of the tissue lumen.

19. A method as in claim 16, wherein the step of removing physiological fluid comprises washing the occluded region to remove physiological fluid.

20. A method as in claim 16, the device comprising a catheter including a flexible elongate tubular shaft and first and second occlusion elements at the distal region of the shaft, the port located between the first and second occlusion elements.

21. A method as in claim 16, further comprising the step of paving the diseased region of the tissue lumen.